WO2009156677A3 - Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé - Google Patents

Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé Download PDF

Info

Publication number
WO2009156677A3
WO2009156677A3 PCT/FR2009/051038 FR2009051038W WO2009156677A3 WO 2009156677 A3 WO2009156677 A3 WO 2009156677A3 FR 2009051038 W FR2009051038 W FR 2009051038W WO 2009156677 A3 WO2009156677 A3 WO 2009156677A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenolic derivative
novel anhydrous
depigmenting compositions
solubilized phenolic
solubilized
Prior art date
Application number
PCT/FR2009/051038
Other languages
English (en)
Other versions
WO2009156677A2 (fr
Inventor
Claire Mallard
Karine Nadau-Fourcade
Fabienne Louis
Original Assignee
Galderma Research & Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research & Development filed Critical Galderma Research & Development
Priority to CN200980120020XA priority Critical patent/CN102046160A/zh
Priority to MX2010012755A priority patent/MX2010012755A/es
Priority to JP2011511072A priority patent/JP2011521935A/ja
Priority to EP09769518A priority patent/EP2291179A2/fr
Priority to US12/994,908 priority patent/US20110144213A1/en
Priority to BRPI0907661-1A priority patent/BRPI0907661A2/pt
Priority to AU2009264013A priority patent/AU2009264013A1/en
Priority to CA2723342A priority patent/CA2723342A1/fr
Publication of WO2009156677A2 publication Critical patent/WO2009156677A2/fr
Publication of WO2009156677A3 publication Critical patent/WO2009156677A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une nouvelle composition dépigmentante anhydre notamment pour une application topique, comprenant, à titre d'actif pharmaceutique, un dérivé phénolique solubilisé dans la phase grasse, à son procédé de préparation et à son utilisation en dermatologie.
PCT/FR2009/051038 2008-05-30 2009-06-02 Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé WO2009156677A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN200980120020XA CN102046160A (zh) 2008-05-30 2009-06-02 包含溶解的酚衍生物的新型无水去色素组合物
MX2010012755A MX2010012755A (es) 2008-05-30 2009-06-02 Nuevas composiciones despigmentantes anhidras que comprenden un derivado fenolico solubilizado.
JP2011511072A JP2011521935A (ja) 2008-05-30 2009-06-02 可溶化フェノール誘導体を含む新規な無水脱色素沈着組成物
EP09769518A EP2291179A2 (fr) 2008-05-30 2009-06-02 Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé
US12/994,908 US20110144213A1 (en) 2008-05-30 2009-06-02 Anhydrous depigmenting compositions comprising a solubilized phenolic compound
BRPI0907661-1A BRPI0907661A2 (pt) 2008-05-30 2009-06-02 ''composição farmacêutica anidra e usos de uma composição''
AU2009264013A AU2009264013A1 (en) 2008-05-30 2009-06-02 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative
CA2723342A CA2723342A1 (fr) 2008-05-30 2009-06-02 Nouvelles compositions depigmentantes anhydre comprenant un derive phenolique solubilise

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0853578 2008-05-30
FR0853578A FR2931663B1 (fr) 2008-05-30 2008-05-30 Nouvelles compositions depigmentantes anhydre comprenant un derive phenolique solubilise.

Publications (2)

Publication Number Publication Date
WO2009156677A2 WO2009156677A2 (fr) 2009-12-30
WO2009156677A3 true WO2009156677A3 (fr) 2010-02-25

Family

ID=39722652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/051038 WO2009156677A2 (fr) 2008-05-30 2009-06-02 Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé

Country Status (12)

Country Link
US (1) US20110144213A1 (fr)
EP (1) EP2291179A2 (fr)
JP (1) JP2011521935A (fr)
KR (1) KR20110026440A (fr)
CN (1) CN102046160A (fr)
AU (1) AU2009264013A1 (fr)
BR (1) BRPI0907661A2 (fr)
CA (1) CA2723342A1 (fr)
FR (1) FR2931663B1 (fr)
MX (1) MX2010012755A (fr)
RU (1) RU2010153984A (fr)
WO (1) WO2009156677A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2946250A1 (fr) * 2009-06-05 2010-12-10 Galderma Res & Dev Compositions topiques depigmentantes, et leurs utilisations.
FR2946249B1 (fr) * 2009-06-05 2012-07-06 Galderma Res & Dev Compositions topiques depigmentantes, et leurs utilisations.
WO2015138926A1 (fr) * 2014-03-14 2015-09-17 Gojo Industries, Inc. Désinfectants pour les mains à caractéristiques améliorées de l'esthétique et de soins de la peau pour encourager le respect des instructions d'hygiène des mains

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466955A (en) * 1982-06-09 1984-08-21 Germaine Monteil Cosmetiques Corporation Skin bleaching stick containing hydroquinone
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US20050260144A1 (en) * 2002-06-25 2005-11-24 Dsm Ip Assets B.V. Benzoxazole and benzodiazole uv-a sunscreens
US20060120979A1 (en) * 2004-12-02 2006-06-08 Joel Rubin Skin care composition comprising hydroquinone and a substantially anhydrous base
WO2006128791A1 (fr) * 2005-06-03 2006-12-07 Isdin, S.A. Nouveaux dérivés de pyrrolyltriazine et méthodes d'obtention desdits dérivés ainsi que leur emploi en tant qu'agents de protection contre les rayonnements uv
FR2894141A1 (fr) * 2005-12-06 2007-06-08 Galderma Res & Dev Composition depigmentante de la peau compreant un derive d'acide naphtoique
FR2915682A1 (fr) * 2007-05-04 2008-11-07 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110449A (en) * 1999-06-14 2000-08-29 The Procter & Gamble Company Anhydrous antiperspirant cream compositions improved perfume longevity
AU2003270272B2 (en) * 2002-09-05 2008-06-19 Galderma Research & Development, S.N.C. Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
DE102004003478A1 (de) * 2004-01-22 2005-08-18 Basf Ag Retinoid-haltige Zubereitungen
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466955A (en) * 1982-06-09 1984-08-21 Germaine Monteil Cosmetiques Corporation Skin bleaching stick containing hydroquinone
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US20050260144A1 (en) * 2002-06-25 2005-11-24 Dsm Ip Assets B.V. Benzoxazole and benzodiazole uv-a sunscreens
US20060120979A1 (en) * 2004-12-02 2006-06-08 Joel Rubin Skin care composition comprising hydroquinone and a substantially anhydrous base
WO2006128791A1 (fr) * 2005-06-03 2006-12-07 Isdin, S.A. Nouveaux dérivés de pyrrolyltriazine et méthodes d'obtention desdits dérivés ainsi que leur emploi en tant qu'agents de protection contre les rayonnements uv
FR2894141A1 (fr) * 2005-12-06 2007-06-08 Galderma Res & Dev Composition depigmentante de la peau compreant un derive d'acide naphtoique
FR2915682A1 (fr) * 2007-05-04 2008-11-07 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KEFALA V ET AL: "THE USE OF BLEACHING AGENTS IN THE MANAGEMENT OF MELASMA", EPITHEORESE KLINIKES FARMAKOLOGIAS KAI FARMAKOKINETIKES - REVIEWOF CLINICAL PHARMACOLOGY AND PHARMACOKINETICS, ATHENS, GR, vol. 17, no. 3, 1 January 2003 (2003-01-01), pages 159 - 163, XP008040149, ISSN: 1011-6583 *
KHEMIS A ET AL: "Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial", BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 156, no. 5, 1 May 2007 (2007-05-01), pages 997 - 1004, XP002462453, ISSN: 0007-0963 *

Also Published As

Publication number Publication date
CA2723342A1 (fr) 2009-12-30
AU2009264013A1 (en) 2009-12-30
FR2931663A1 (fr) 2009-12-04
MX2010012755A (es) 2010-12-21
BRPI0907661A2 (pt) 2015-07-21
EP2291179A2 (fr) 2011-03-09
WO2009156677A2 (fr) 2009-12-30
KR20110026440A (ko) 2011-03-15
JP2011521935A (ja) 2011-07-28
RU2010153984A (ru) 2012-07-10
US20110144213A1 (en) 2011-06-16
FR2931663B1 (fr) 2010-07-30
CN102046160A (zh) 2011-05-04

Similar Documents

Publication Publication Date Title
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
PT2344198T (pt) Preparações farmacêuticas à base de lípidos para aplicação tópica
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
PT2821386T (pt) Composição cosmética, dermatológica ou farmacêutica que compreende pelo menos um derivado de vanilina como conservante
WO2008116135A3 (fr) Formulations topiques ayant une biodisponibilité amplifiée
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2010002586A3 (fr) Compositions topiques contenant de l’isonicotinamide
WO2011019468A3 (fr) Composition topique ayant un effet éclaircissant sur la peau
WO2011014850A3 (fr) Formulations à usage topique à base d'un eutectique
WO2010092088A3 (fr) Utilisation d'hydrophobine en tant qu'agent mouillant
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
WO2009004629A3 (fr) Procédé pour réduire les symptômes de consommation d'alcool
WO2010021607A3 (fr) Préparation pharmaceutique
WO2010043717A3 (fr) Compositions topiques pharmaceutiques
WO2009141541A3 (fr) Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
WO2011043631A3 (fr) Composition pharmaceutique pour la prévention et le traitement du rhume, contenant un extrait de reynoutria elliptica, une fraction de celui-ci ou un composé à base de stilbène
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2010062122A3 (fr) Composition pour empêcher ou traiter l'athérosclérose
WO2009101321A3 (fr) Composés cationiques tensioactifs, leur utilisation comme conditionneur, procédé de traitement cosmétique, et compositions cosmétiques ou pharmaceutiques les comprenant
WO2009156677A3 (fr) Nouvelles compositions dépigmentantes anhydre comprenant un dérivé phénolique solubilisé
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980120020.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09769518

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009769518

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2723342

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 4382/KOLNP/2010

Country of ref document: IN

Ref document number: MX/A/2010/012755

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011511072

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009264013

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 20107029555

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010153984

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2009264013

Country of ref document: AU

Date of ref document: 20090602

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12994908

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0907661

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20101029